$41.29
-0.99 (-2.33%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+8.79%
1Y
+280.16%
YTD
+18.84%
Open$41.88
Previous Close$42.27
Day High$42.77
Day Low$41.25
52W High$43.73
52W Low$10.38
Volume—
Avg Volume1.67M
Market Cap6.65B
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$37.85
Above
SMA 200
$20.09
Above
RSI (14)
53
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+103.4% upside
Current
$41.29
$41.29
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.66B | 1.76B | 1.56B |
| Net Income | -282,006,496 | -354,880,166 | -268,142,716 |
| Profit Margin | -17.0% | -20.2% | -17.2% |
| EBITDA | -474,772,680 | -496,954,417 | -453,512,070 |
| Free Cash Flow | -249,995,996 | -301,722,393 | -268,935,506 |
| Rev Growth | -0.8% | +1.9% | -1.2% |
| Debt/Equity | 0.59 | 0.54 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |